Trazumab 150 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Trazumab 150 mg Injection

Trazumab 150 mg Injection

Trazumab 150 mg Injection contains trastuzumab and is a targeted anticancer medicine used for certain HER2-positive cancers. It works by binding to the HER2 protein and helping slow the growth of cancer cells. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Trastuzumab is a monoclonal antibody that targets the HER2 protein found in increased amounts on some cancer cells. Trazumab 150 mg Injection is used in treatment regimens for appropriate patients with HER2-positive breast cancer and other HER2-positive cancers. The medicine requires proper preparation and controlled intravenous administration according to the prescribed treatment protocol. Patients may require monitoring of heart function, infusion reactions, blood counts, and other treatment-related effects during therapy.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 150 mg
Dosage Form Powder for Solution for Infusion
Pack Size 1 Vial
Route of Administration Intravenous Infusion
Manufacturer Emcure Pharmaceuticals Ltd

Product Also Known As

Trazumab 150 mg, Trazumab 150 mg Injection, Trazumab 150 mg Infusion, Trastuzumab 150 mg Injection, Trastuzumab 150 mg Infusion, Trastuzumab Injection, HER2 Targeted Therapy Injection